IRON logo

IRON
Disc Medicine Inc

386
Mkt Cap
$2.56B
Volume
342,496.00
52W High
$99.50
52W Low
$40.00
PE Ratio
-10.10
IRON Fundamentals
Price
$66.82
Prev Close
$67.13
Open
$67.18
50D MA
$65.93
Beta
1.14
Avg. Volume
390,483.05
EPS (Annual)
-$6.01
P/B
3.71
Rev/Employee
$0.00
$2,042.70
Loading...
Loading...
News
all
press releases
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON PR Newswire NEW YORK, May 18, 2026 NEW YORK, May 18, 2026...
News Placeholder
More News
News Placeholder
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON PR Newswire NEW YORK, May 6, 2026 NEW YORK, May 6, 2026...
News Placeholder
Disc Medicine (NASDAQ:IRON) Releases Quarterly Earnings Results, Misses Estimates By $0.03 EPS
Disc Medicine (NASDAQ:IRON - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($1.65) EPS for the quarter, missing the consensus estimate of ($1.62) by ($0.03...
News Placeholder
Jennison Associates LLC Takes Position in Disc Medicine, Inc. $IRON
Jennison Associates LLC purchased a new position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 532,079 shares of the company's stock, valued at approx...
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc...
News Placeholder
Pictet Asset Management Holding SA Grows Stock Holdings in Disc Medicine, Inc. $IRON
Pictet Asset Management Holding SA boosted its stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 10,968.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 394,374 shares of the company's stock after acquiring an...
News Placeholder
Disc Medicine (IRON) Projected to Post Earnings on Thursday
Disc Medicine (NASDAQ:IRON) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at...
News Placeholder
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About...
News Placeholder
Disc Medicine (NASDAQ:IRON) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Disc Medicine from a "strong sell" rating to a "sell" rating in a research report on Saturday...
News Placeholder
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) have received an average recommendation of "Moderate Buy" from the twelve ratings firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assig...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available